Medication dose captures modification of hypertension treatment intensity more precisely than medication count, and this measure should be preferred in studies that aim to improve hypertension ...

There are improved outcomes in patients with isolated systolic hypertension and frailty who receive antihypertensive therapy. Antihypertensive therapy is associated with improved outcomes among ...

July 23, 2010 — Continuing antihypertensive medication after a stroke does not appear to reduce 2-week death or dependency, cardiovascular event rate, or mortality at 6 months, according to new ...

In patients with hypertension, starting therapy with an angiotensin receptor blocker (ARB) is associated with the best ...

Please provide your email address to receive an email when new articles are posted on . Researchers observed no difference in 3-month functional outcomes or mortality among patients with acute ...

44.7 percent of angiotensin receptor blocker initiators were continuously persistent to original drug class at three years.

Antihypertensive treatment in later life may prevent Alzheimer’s disease. All-cause dementia risk was elevated in the presence of high BP and not significantly affected by treatment. Treating high ...

In treating hypertension to blood pressure goal levels, undue orthostatic hypotension sometimes occurs. Is there an agent or class of antihypertensive agents more or less likely to cause this effect?

Idorsia receives approval from Health Canada for JERAYGO™ (aprocitentan) as the first and only endothelin receptor antagonist ...

Anyone who recalls the 1971 Loving Care commercial exclaiming, 'You're not getting older. You're getting better!' is getting older. America is graying -- in 2019, people older than 65 years accounted ...